Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 42 people, planned
- Started
- 11 Feb 2025
- Expected to end
- 11 Feb 2027
- Type of study
- Interventional
- Treatments tested
- Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN)
- Record updated
- 30 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Post-resuscitation GCS score 12 or below and acute trauma-related intradural blood on head CT scan after TB
- Age 18 years or older (pediatric trauma patients are not routinely transported to Parkland)
- Consent from legally authorized representative
Who cannot take part
- Unclear neurological status because of paralytic medications or intoxication with ethanol or other drugs
- Abnormal ear anatomy or ear infection
- Hemodynamic instability
- Expected imminent mortality because of overwhelming neurological and/or systemic injury
- Presence of other electrical stimulation devices (pacemaker, cochlear prosthesis, neurostimulator, etc.)
- Participant is pregnant or lactating
- Any other significant medical or psychosocial problems that, in the opinion of the investigator, would potentially cause harm to the participant, impact their ability to participate, or influence the results of the trial
This trial is currently available in United States.
- Parkland Health & Hospital SystemDallas, United StatesContact: Alex Valadka, MDTaking people
- UT Southwestern Medical CenterDallas, United StatesContact: Alex Valadka, MDTaking people
About the trial
What the trial wants to find out
The overarching goal of this pilot study is to assess the feasibility and safety of transcutaneous auricular neurostimulation (tan) in ICU patients with TBi and to determine the effect of tan on serum markers of inflammation. exploratory analyses will examine effects on such physiological parameters as blood pressure, heart rate, and intracranial pressure (iCP), as well as measures of neurological function.
The group in the trial
- Determine the effect of tAN on serum concentrations of inflammatory mediators in TBI patientsTreatment being tested
Subjects will receive treatment upon providing informed consent and will undergo transcutaneous auricular neurostimulation (tAN) once daily during their ICU stay, with the treatment duration not exceeding 10 days. Two blood samples will be collected daily: one before the tAN session and another two hours after the session. Participant data will be collected daily throughout the ICU stay. Additionally, surveys will be collected from registered nurses providing direct care to TBI patients enrolled in the tAN-TBI study to assess the compatibility of tAN with patient care processes in the ICU.
Treatment: Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Delivering Transcutaneous Auricular Neurostimulation (tAN) to ICU Patients With Traumatic Brain Injury (tAN-TBI)
- Record updated
- 30 September 2026